
© Wikimedia CommonsStrophanthus gratus
A recent
article in the
New York Times about a study published last month in
The Lancet, perhaps the most prestigious medical journal in the world, is no doubt creating a stir in the conventional-cardiology world. The headline was "
Unbelievable": Heart Stents Fail to Ease Chest Pain. The study was actually the second of two very interesting studies published by
The Lancet, both of which seriously challenge core beliefs and practices in modern cardiology. It was conducted in England, where, for the first time, the authors compared the chest pain of patients who had stents placed compared to those who had a dummy procedure, in which catheters were inserted but stents were not placed.
Studies
(1) have already shown that stents and bypasses don't prevent future heart attacks or increase longevity.
To the shock of many cardiologists who commented on the study, there was no difference in outcome of those who had the stent compared with those who had the dummy procedure. This result means the final claim made by stent proponents - symptom control - also turns out to be untrue. At this point, it is hard to understand the rationale for the use of stents in any condition except, possibly, in the acute treatment of an ongoing heart attack involving the proximal part of the left anterior descending coronary artery, which, cardiologists say, improves the outcome.
While many cardiologists expressed surprise and even dismay at the results, for those of you who have followed my writings on the cause and treatment of angina and heart attacks, this finding will come as no surprise. Many factors other than lesions in the coronary arteries lead people to suffer from heart disease. Until cardiologists learn to look at the imbalance in the autonomic nervous system, the microcirculation and the build-up of lactic acid in the heart cells, no resolution of our heart-disease epidemic will be found. Unfortunately, a safe and effective medicine that addresses these factors,
strophanthus/ouabain, is sadly overlooked and forgotten in conventional cardiology circles
Comment: The story of ouabain